A lengthy preclinical AD phase offers the chance for intervention,11 such as engagement in physical activity or increasing adherence to physical activity, to positively impact the disease before clinical symptom onset.12,13 However, limited work has been done to understand the association of physical activity and total tau concentrations with cognitive decline. The gene discussed is MAPT; the disease is Mental deterioration.